https://www.devdiscourse.com/article/technology/3454167-novo-nordisk-sets-new-benchmark-with-cagrisema-obesity-trial
Novo Nordisk has launched a late-stage trial for its obesity drug candidate, CagriSema, aiming to restore market confidence after previous studies showed...
novo nordisksetsnewbenchmarkcagrisema